The Global Adenosine Injection market is expected to reach $xx Mn in 2026 from $xx Mn in 2020, at a CAGR of xx% during the forecast period.
Market Overview & Dynamics:
Adenosine is an endogenous nucleoside occurring in all cells of the body. Adenosine Injection is administered intravenously used generally as cardiovascular drugs and antiarrhythmic agents. It is given to patients suffering from Wolff-Parkinson-White Syndrome, paroxysmal supraventricular tachycardia, and other myocardial diseases.